Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDySunao Kojima, Hisao Ogawa, Kunihiko Matsui et al.|European Heart Journal|2019Cited by 229
Update in uric acid, hypertension, and cardiovascular diseasesMasanari Kuwabara, Miguel A. Lanaspa, Takahide Kodama et al.|Hypertension Research|2023Cited by 85
Cause of Persistent Hypouricemia in OutpatientsIchiro Hisatome, Shoji Nakamoto, Kazuhíde Oginö et al.|The Nephron journals/Nephron journals|2008Cited by 70
Molecular Mechanisms Underlying Urate-Induced Enhancement of Kv1.5 Channel Expression in HL-1 Atrial MyocytesNani Maharani, Ichiro Hisatome|Circulation Journal|2015Cited by 63
Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemiaSunao Kojima, Yoshihiko Saito, Kunihiko Matsui et al.|Journal of Cardiology|2016Cited by 43